Biomedical applications of gold nanoparticles

Current Topics in Medicinal Chemistry

Volumn 15, Issue 16, 2015, Pages 1605-1613

  Cabuzu, Daniela ^a   Cirja, Andreea ^a   Puiu, Rebecca ^a   Grumezescu, Alexandru Mihai ^a  

^a UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

Author keywords

Biocompatibility; Bioimaging; Biomedical applications; Delivery; Gold nanoparticles; Nanomedicine; Targeting

Indexed keywords

ACORUS CALAMUS EXTRACT; CARBOHYDRATE ANTIGEN; CHITOSAN OLIGOSACCHARIDE; CITRIC ACID; GOLD NANOPARTICLE; GYMNEMA SYLVESTRE EXTRACT; MOLECULAR SCAFFOLD; OLIGOSACCHARIDE; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG; AMYLOID; GOLD; METAL NANOPARTICLE;

ARTICLE; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CYTOTOXICITY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; GAMMA IRRADIATION; GENOTOXICITY; HEART PROTECTION; HUMAN; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; NONHUMAN; PHOTODYNAMIC THERAPY; PLANT LEAF; REDUCTION; STREPTOMYCES; SYNTHESIS; TOXICITY; ALZHEIMER DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; NEOPLASMS; PARTICLE SIZE; PROCEDURES; THERANOSTIC NANOMEDICINE;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; DIAGNOSTIC IMAGING; GOLD; HUMANS; METAL NANOPARTICLES; NEOPLASMS; PARTICLE SIZE; THERANOSTIC NANOMEDICINE;

EID: 84930886579     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150414144750     Document Type: Article

References (101)

1. Atta, N. F.; Galal, A.; Abu-Attia, F. M.; Azab, S. M. Carbon paste gold nanoparticles sensor, for the elective determination of dopamine in buffered solutions. J. Electrochem. Soc., 2010, 157(9), F116-F123.
2. Goyal, R. N.; Aliumar, A.; Oyama, M. Comparison of spherical nanogold particles and nanogold plates for the oxidation of dopamine and ascorbic acid. J. Electroanal. Chem., 2009, 631, 58-61.
3. Quczak, T. Comparison of electrochemical oxidation of epinephrine in the presence of interfering ascorbic and uric acids on gold electrodes modified with S-functionalized compounds and gold nanoparticles. Electrochim. Acta., 2009, 54, 5863-5870.
4. Alvarez, M. M.; Khoury, J. T.; Schaaff, T. G.; Shafigullin, M. N.; Vezmar, I.; Whetten, R. L. Optical absorption spectra of nanocrystal gold molecules. J. Phys. Chem. B., 1997, 101(19), 3706-3712.
5. Lopez-Acevedo, O.; Tsunoyama, H.; Tsukuda, T.; Hakkinen, H.; Aikens, C. M. Chirality and electronic structure of the thiolate protected Au-38 nanocluster. J. Am. Chem. Soc., 2010, 132(23), 8210-8218.
6. Bukasov, R.; Shumaker-Parry, J. S. Highly tunable infrared extinction properties of gold nanocrescents. Nano Lett., 2007, 7(5), 1113-1118.
7. Millstone, J. E.; Park, S.; Shuford, K. L.; Qin, L. D.; Schatz, G. C.; Mirkin, C. A. Observation of a quadrupole plasmon mode for a colloidal solution of gold nanoprisms. J. Am. Chem. Soc., 2005, 127 (15), 5312-5313.
8. Burda, C.; Chen, X. B.; Narayanan, R.; El-Sayed, M. A. Chemistry and properties of nanocrystals of different shapes. Chem. Rev., 2005, 105(4), 1025-1102.
9. Hostetler, M. J.; Zhong, C. J.; Yen, B. K. H.; Anderegg, J.; Gross, S. M.; Evans, N. D. Stable, monolayer-protected metal alloy clusters. J. Am. Chem. Soc., 1998, 120(36), 9396-9397.
10. Mohr, C.; Hofmeister, H.; Claus, P. The influence of real structure of gold catalysts in the partial hydrogenation of acrolein. J. Catal., 2003, 213(1), 86-94.
11. Biswas, S.; Medina, S. H.; Barchi, Jr. J. J. Synthesis and cellselective antitumor properties of amino acid conjugated tumorassociated carbohydrate antigen-coated gold nanoparticles. Carbohydrate Res., 2014.
12. Lewis, D. J.; Pikramenou, Z. Lanthanide-coated gold nanoparticles for biomedical applications. Coordination Chem. Rev., 2014, 273-274, 213-225.
13. Correa-Lianten, D. N.; Munoz-Ibacache, S. A.; Castro, M. E.; Munoz, P. A.; Blamey, J. M. Gold nanoparticles synthesized by Geobacillus sp. strain ID17 a thermophilic bacterium isolated from Deception Island Antarctica. Microb. Cell. Fact., 2013, 12, 75.
14. Li, Q.; Lu, B.; Zhang, L.; Lu, C. Synthesis and stability evaluation of size-controlled gold nanoparticles via nonionic fluorosurfactant assisted hydrogen peroxide reduction. J. Mater. Chem., 2012, 22, 13564-13570.
15. Sharma, N.; Pinnaka, A. K.; Raje, M.; Ashish, F. N. U.; Bhattacharyya, M. S.; Choudhury, A. R. Exploitation of marine bacteria for production of gold nanoparticles. Microb. Cell. Fact., 2012, 11, 86.
16. Das, S. K.; Liang, J.; Schmidt, M.; Laffir, F.; Marsili, E. Biomineralization mechanism of gold by zygomycete fungi Rhizopousoryzae. ACS. Nano., 2012, 6, 6165-6173.
17. Adavallan, K.; Krishna kumar, N. Mulberry leaf extract mediated synthesis of gold nanoparticles and its anti-bacterial activity against human pathogens. Adv. Nat. Sci: Nanosci. Nanotechnol., 2014, 5, 025018.
18. Ashokkumar, T.; Prabhuc, D.; Geethaa, R.; Govindarajub, K.; Manikandanc, R. Chinnasamy Arulvasuc, Ganesan Singaravelu. Apoptosis in liver cancer (HepG2) cells induced by functionalized gold nanoparticles. Coll. Surf. B.: Biointer., 2014, 123, 549-556.
19. Ganesan, R. M.; Gurumallesh Prabu, H. Synthesis of gold nanoparticles using herbal Acorus calamus rhizome extract and coating on cotton fabric for antibacterial and UV blocking applications. Arabian J. Chem., 2015. doi: 10. 1016/j. arabjc. 2014. 12. 017.
20. Karthick, V.; Kumar, V. G.; Dhas, T. S.; Singaravelu, G.; Sadiq, A. M.; Govindaraju, K. Effect of biologically syntesized gold nanoparticles on alloxan-induced diabetic rats-An in vivo approach. Coll. Surfaces B.: Biointer., 2014, 122, 505-511.
21. Khoa, D. N. V.; Christelle, K.; Laurent, D.; Xavier, C.; Nguyen, Q. H. Radiation synthesis of chitosan stabilized gold nanoparticles comparison between e-beam and γ irradiation. Radiat. Phys. Chem., 2014, 94, 84-7.
22. Nguyen, T. A.; Dang, V. P.; Nguyen, N. D.; Bui, D. D.; Nguyen, Q. H. Synthesis of alginate stabilized gold nanoparticles by γ-irradiation with controllable size using different Au3+concentration and seed particles enlargement. Radiat. Phys. Chem., 2010, 79, 405-8.
23. Sangeeta, K.; Raj, P. S. Glycolic acid functionalized chitosan-AuFe3O4 hybrid nanoparticle based nanohybrid scaffold ford rug delivery. Int. J. Biol. Macromol., 2013, 54, 244-9.
24. Ying, X. Y.; Dan, C.; Lian, Y.; Du, Y. Z. Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin. Carbohydr. Polym., 2011, 84, 1357-64.
25. Hu, F. Q.; Zhao, M. D.; Yuan, H.; You, J.; Du, Y. Z.; Zeng, S. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitrot ransfection studies. Int. J. Pharm., 2006, 315, 158-66.
26. Chater, K. F. Genetics of differentiation in Streptomyces. Annu. Rev. Microbiol., 1993, 47, 685-711.
27. Sadhasivam, S.; Shanmugam, P.; Yun, K. Biosynthesis of silver nanoparticles by Streptomyces hygroscopicus and antimicrobial activity against medically important pathogenic microorganisms. Colloids Surf. B. Biointerfaces, 2010, 81, 358-362.
28. Sadhasivam, S.; Shanmugam, P.; Veerapandian, M.; Subbiah, R.; Yun, K. Biogenic synthesis of multidimensional gold nanoparticles assisted by Streptomyces hygroscopicus and its electrochemical and antibacterial properties. Biometals, 2012, 25, 351-360.
29. Plackett, R. L.; Burman, J. P. The design of optimum multifactorial experiments, Biometrika, 1946, 33, 305-325.
30. Bednarski, M.; Dudek, M.; Knutelska, J.; Nowinski, L.; Sapa, J.; Zygmunt, M.; Nowak, G.; Luty-Blocho, M.; Wojnicki, M.; Fitzner, K.; Teriorowski, M. The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies. Pharmacol. Rep., 2015, 67(3), 405-9.
31. Suryanarayana, C.; Norton, M. X-ray diffraction: a practical approach. Microsc. Microanal., 1998, 4, 513-515.
32. Hanžić, N.; Jurkin, T.; Maksimović, A.; Gotić, M. The synthesis of gold nanoparticles by a citrate-radiolytical method. Radiation Phys. Chem., 2015, 106, 77-82.
33. Kah, C.; Kho, K. W.; Lee, C. G.; James, C.; Sheppard, R.; Shen, Z. X.; Soo, K. C.; Olivo, M. C. Early diagnosis of oral cancer based on the surface plasmon resonance of goldnanoparticles. Int. J. Nanomed., 2007, 2, 785-798.
34. Podsiadlo, P.; Sinani, V. A.; Bahng, J. H.; Kam, N. W.; Lee, J.; Kotov, N. A. Goldnanoparticlesenhance the anti-leukemia action of a 6-mercaptopurine chemotherapeutic agent. Langmuir, 2008, 24, 568-574.
35. Huang, X.; Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A. Gold nanoparticles: interestingoptical properties and recent applications in cancer diagnostics and therapy. Nanomedicine, 2007, 2, 681-693.
36. Karamipour, Sh.; Sadjadi, M. S.; Farhadyar, N. Fabrication and spectroscopic studies of folic acid-conjugated Fe3O4@Au core-shell for targeted drug delivery application. Spect. Acta Part A: Mol. Biom. Spect., 2015, 148, 146-155.
37. De Jong, W. H.; Hagens, W. I.; Krystek, P.; Burger, M. C.; Sips, A. J.; Geertsma, R. E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials, 2008, 29, 1912-9.
38. Sonavane, G.; Tomoda, K.; Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Coll. Surf. B. Biointer., 2008, 66, 274-80.
39. Ng, Q. K.; Olariu, C. I.; Yaffee, M.; Taelman, V. F.; Marincek, N.; Krause, T.; Meier, L.; Walter, M. A. Indium-111 labeled gold nanoparticles for in-vivo molecular targeting. Biomaterials, 2014, 35, 7050-7057.
40. Choi, H. S.; Liu, W.; Misra, P.; Tanaka, E.; Zimmer, J. P.; Ipe, B. I. Renal clearance of quantum dots. Nat Biotech., 2007, 25, 1165-70.
41. Sonavane, G.; Tomoda, K.; Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Coll. Surf. B. Biointer., 2008, 66, 274-80.
42. Farrell, N. Transition metal complexes as drugs and chemotherapeutic agents. MA: Kluwer Academic Publishing, 1989.
43. Herold, D. M.; Das, I. J.; Stobbe, C. C.; Iyer, R. V.; Chapman, J. D. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int. J. Radiat. Biol., 2000, 76, 1357-64.
44. Bakri, S. J.; Pulido, J. S.; Mukherjee, P.; Marler, R. J.; Mukhopadhyay, D. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model. Retina, 2008, 28, 147-9.
45. Zhang, L. W.; Yu, W. W.; Colvin, V. L.; Monteiro-Riviere, N. A. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol. Appl. Pharmacol., 2008, 228, 200-11.
46. Connor, E.; Mwamuka, J.; Gole, A.; Murphy, C.; Wyatt, M. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small, 2005, 1, 325-327.
47. Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, U. Size-dependent cytotoxicity of gold nanoparticles. Small, 2007, 3, 1941-1949.
48. Kang, J.; Yum, Y.; Kim, J.; Song, H.; Jeong, J.; Lim, Y. Induction of DNA damagein L5178Y cells treated with gold nanoparticle. Biomol. Ther., 2009, 17, 92-97.
49. Li, J.; Zou, L.; Hartono, D.; Ong, C.; Bay, B.; Yung, L. Gold nanoparticles induce oxidative damage in lung fibroblasts in vitro. Adv. Mater., 2008, 20, 138-142.
50. Labouta, H.; Schneider, M. Tailor-made biofunctionalized nanoparticles using layer-by-layer technology. Int. J. Pharm., 2010, 395, 236-242.
51. Jong, W.; Hagens, W.; Krystek, P.; Burger, M.; Sips, A.; Geertsma, R. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials, 2008, 29, 1912-1919.
52. Chithrani, B.; Ghazani, A.; Chan, W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett., 2006, 6, 662-668.
53. Kah, J. C.; Wong, K. Y.; Neoh, K. G.; Song, J. H.; Fu, J. W.; Mhaisalkar, S.; Olivo, M.; Sheppard, C. J. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J. Drug Target., 2009, 17, 181-193.
54. Sattler, K. D. Handbook of nanophysics: nanomedicineand nanorobotics. CRC Press, Boca Raton, 2011.
55. Huang, X.; Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci., 2008, 23, 217-228.
56. Wang, Z. L.; Ze Zhang, Z.; Liu, Y. Handbook of nanophase and nanostructured materials. Springer, New York, 2003.
57. Puvanakrishnan, P.; Park, J.; Chatterjee, D.; Krishnan, S.; Tunnell, J. In vivo tumor targeting of gold nanoparticles: effect of particle type and dosing strategy. Int. J. Nanomedicine, 2012, 7, 1251-1258.
58. Streszewski, B.; Jaworski, W.; Pacawski, K.; Csapo, E.; Dekany, I.; Fitzner, K. Gold nanoparticles formation in the aqueous system of gold(III) chloride complex ions and hydrazine sulfate-Kinetic studies. Colloids Surf. A. Physicochem. Eng. Asp., 2012, 397, 63-72.
59. Zhang, X. D.; Wu, D.; Shen, X.; Liu, P. X.; Yang, N.; Zhao, B.; Zhang, H. Size-dependent in vivo toxicity of PEG coated gold nanoparticles. Int. J. Nanomedicine, 2011, 6, 2071-2081.
60. Bac, L. H.; Kim, J. S.; Kim, J. C. Size, optical and stability properties of gold nanoparticles synthesized by electrical explosion of wire in different aqueous media. Rev. Adv. Mater Sci., 2011, 28, 117-121.
61. Jain, P. K.; Lee, K. S.; El-Sayed, I. H.; El-Sayed, M. A. Calculated absorption and scattering properties of gold nanoparticles of different size, shape and composition: applications in biological imaging and biomedicine. J. Phys. Chem. B., 2006, 110, 7238-7248.
62. Hainfeld, J. F.; Lin, L.; Slatkin, D. N.; Dilmanian, F. A.; Vadas, T. M.; Smilowitz, H. M. Gold nanoparticle hyperthermia reduces radiotherapy dose. Nanomed. Nanotech. Biol. Med., 2014, 10, 1609-1617.
63. O'Neal, D. P.; Hirsch, L. R.; Halas, N. J.; Payne, J. D.; West, J. L. Photothermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett., 2004, 209, 171-6.
64. Zhang, S. X.; Gao, J.; Buchholz, T. A.; Wang, Z.; Salehpour, M. R.; Drezek, R. A.; Yu, T. K. Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a monte carlo simulation study. Biomed. Microdev., 2009, 11, 925-933.
65. Park, J.; Estrada, A.; Sharp, K.; Sang, K.; Schwartz, J. A.; Smith, D. K.; Coleman, C.; Payne, J. D.; Korgel, B. A.; Dunn, A. K.; Tunnell, J. W. Two-photon-induced photoluminescence imaging of tumors using near-infrared excited gold nanoshells. Optics Express, 2008, 16, 1590-1599.
66. Hsieh, J. W.; Chang, C.-W.; Chou, H.-H. Gold nanoparticles asamyloid-like fibrillogenesis inhibitors. Coll. Surf. B.: Biointer., 2013, 112, 525-529.
67. Almogren, A.; Abdullah, J.; Ghapure, K.; Ferguson, K.; Glinsky, V. V.; Rittenhouse-Olson, K. Anti-Thomsen-Friedenreich-Ag (antiTF-Ag) potential for cancer therapy. Front. Biosci., 2012, 4, 840-63.
68. Biswas, S.; Medina, S. H.; Barchi J. J. Jr. Synthesis and cellselective antitumor properties of amino acid conjugated tumorassociated carbohydrate antigen-coated gold nanoparticles. Carbohydr. Res., 2015, 405, 93-101.
69. Lewis, D. J.; Pikramenou, Z. Lanthanide-coated gold nanoparticles for biomedical applications. Coord. Chem. Rev., 2014, 273-274, 213-225.
70. Jaffer, F. A. Weissleder R. Molecular imaging in the clinical arena. J. Am. Med. Assoc., 2005, 293, 855-62.
71. Velikyan, I. Molecular imaging and radiotherapy: theranostics for personalized patient anagement. Theranostics, 2012, 2, 424-6.
72. Libutti, S. K.; Paciotti, G. F.; Byrnes, A. A.; Alexander, Jr H. R.; Gannon, W. E.; Walker, M. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res., 2010, 16, 6139-49.
73. Montet, X.; Funovics, M.; Montet-Abou, K.; Weissleder, R.; Josephson, L. Multivalent effects of RGD peptides obtained by nanoparticle display. J. Med. Chem., 2006, 49, 6087-93.
74. Weintraub, K. Biomedicine: the new gold standard. Nature, 2013, 495, S14-6.
75. Lee, J.; Chatterjee, D. K.; Lee, M. H.; Krishnan, S. Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls. Cancer Letters, 2014, 347, 46-53.
76. Daniel, M. C.; Astruc, D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev., 2004, 104, 293-346.
77. Truman, L. K.; Comby, S.; Gunnlaugsson, T. pH-responsive luminescent lanthanide-functionalized gold nanoparticles with "onoff" ytterbium switchable near-infrared emission. Angew. Chem. Int. Ed., 2012, 51, 9624-9627.
78. Aime, S.; Gianolio, E.; Barge, A.; Kostakis, D.; Plakatouras, I. C.; Hajiliadis, N. Modulation of the Prototropic Exchange Rate at the Water Molecule Coordinated to a GdIII Ion. Eur. J. Inorg. Chem., 2003, 11, 2045-2048.
79. Balansky, R.; Longobardi, M.; Ganchev, G.; Iltcheva, M.; Nedyalkov, N.; Atanasov, P.; Toshkova, R.; De Flora, S.; Izzotti, A. Transplacental clastogenic and epigenetic effects of goldnanoparticles in mice. Mutation Res., 2013, 751-752, 42-48.
80. Agyare, E. K.; Curran, G. L.; Ramakrishnan, M.; Yu, C. C.; Poduslo, J. F.; Kandimalla, K. K. Development of asmartnano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy. Pharm. Res., 2008, 25, 2674-2684.
81. Zhuang, Z. P.; Kung, M. P.; Hou, C.; Skovronsky, D. M.; Gur, T. L.; Plossl, K.; Trojanowski, J. Q.; Lee, V. M.; Kung, H. F. Radio iodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J. Med. Chem., 2001, 44, 1905-1914.
82. Kogan, M. J.; Bastus, N. G.; Amigo, R.; Grillo-Bosch, D.; Araya, E.; Turiel, A.; Labarta, A.; Giralt, E.; Puntes, V. F. Nanoparticlemediated local and remote manipulation of protein aggregation. Nano-Lett., 2006, 6, 110-115.
83. Vinodhini, A.; Govindaraju, K.; Singaravelu, G.; Mohamed Sadiq, A.; Kumar, V. G. Cardioprotective potential of biobased gold nanoparticles. Coll. Surf. B. Biointer., 2014, 117, 480-486.
84. Hanefeld, M.; Herrmann, K. Uber das Vorkommen von Proanthocyanidinen, Leukoanthocyanidinen und Catechinen im Gemuse. Zeitschrift Lebensmittel-Untersuchung Forschung., 1976, 161, 243-248.
85. Fine, A. M. Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern. Med. Rev., 2000, 5(2), 144-151.
86. Rezin, G. T.; Zanoni, E. T.; de Souza Notoya, F.; Leffa, D. D.; Damiani, A. P.; Daumann, F.; Ortiz Rodriguez, J. C.; Benavides, R.; da Silva, L.; Andrade, V. M.; da Silva Paula, M. M. Acute and chronic administration of gold nanoparticles cause DNAdamage in the cerebral cortex of adult rats. Mutation Res., 2014, 766-767, 25-30.
87. Aillon, K. L.; Xie, Y.; El-Gendy, N.; Berkland, C. J.; Forrest, M. L. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev., 2009, 61, 457-466.
88. Johnston, H. J.; Hutchison, G.; Christensen, F. M.; Peters, S.; Hankin, S.; Stone, V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol., 2010, 40, 328-346.
89. Khlebtsov, N.; Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev., 2011, 40, 1647-1671.
90. Tsoli, M.; Kuhn, H.; Brandau, W.; Esche, H.; Schmid, G. Cellular uptake and toxicityof Au55 clusters. Small, 2005, 1, 841-844.
91. Aillon, K. L.; Xie, Y.; El-Gendy, N.; Berkland, C. J.; Forrest, M. L. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev., 2009, 61, 457-466.
92. Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size-dependent cytotoxicity of gold nanoparticles. Small, 2007, 3, 1941-1949.
93. Chen, Y. H.; Tsai, C. Y.; Huang, P. Y.; Chang, M. Y.; Cheng, P. C.; Chou, C. H.; Chen, D. H.; Wang, C. R.; Shiau, A. L.; Wu, C. L. Methotrexate conjugated to gold nanoparticlesinhibits tumor growth in a syngeneic lung tumor model. Mol. Pharm., 2007, 4, 713-722.
94. Johnston, H. J.; Hutchison, G.; Christensen, F. M.; Peters, S.; Hankin, S.; Stone, V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol., 2010, 40, 328-346.
95. Khlebtsov, N.; Dykman, L. Biodistribution and toxicity of engineered goldnanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev., 2011, 40, 1647-1671.
96. Tsoli, M.; Kuhn, H.; Brandau, W.; Esche, H.; Schmide, G. Cellular uptake and toxicity of Au55 clusters. Small, 2005, 1, 841-844.
97. Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size-dependent cytotoxicity of gold nanoparticles. Small, 2007, 3, 1941-1949.
98. Semmler-Behnke, M.; Fertsch, S.; Schmid, G.; Wenk, A.; Kreyling, W. G. Uptake of 1. 4 nm versus 18 nm gold nanoparticles in secondary target organs is sizedependent in control and pregnant rats after intratracheal or intravenous application. Euro. Nano. Forum, 2007, 102.
99. Semmler-Behnke, M.; Fertsch, S.; Schmid, G.; Wenk, A.; Kreyling, W. G. Uptake of 1. 4 nm versus 18 nm gold nanoparticlesin secondary target organs is sizedependent in control and pregnant rats after intratracheal or intravenous application. Euro. Nano. Forum, 2007, 102.
100. Hainfeld, J. F.; Slatkin, D. N.; Focella, T. M.; Smilowitz, H. M. Gold nanoparticles: a new X-ray contrast agent. Br. J. Radiol., 2006, 79, 248-253.
101. Khlebtsov, N.; Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev., 2011, 40, 1647-71.